Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for cognitive flexibility under stress
NL-OMON25919Not yet recruiting
- Sponsor
- Maastricht University
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of psilocybin in post-traumatic stress disorder (PTSD), sponsored by Maastricht University. Primary endpoints: Change in divergent thinking and Change in goal-directed versus habitual behavior. Planned start May 2017; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON25919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25919.